Maitenance therapy with bortezomib for multiple myeloma after autologus stem cell transplantatio
Not Applicable
- Conditions
- multiple myeloma
- Registration Number
- JPRN-UMIN000007188
- Lead Sponsor
- niversity Of Tokyo Hospital, Department of Hematology and Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Allergy for Bortezomib, mannitol, and boron. 2. A woman during pregnancy or potential pregnancy. 3. Patients who cannot stop drugs or therapy restricted in this trial. 4. Patients who are recoginized as inadaptable for this trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method